1395492-90-6Relevant articles and documents
SPIROCYCLIC COMPOUNDS
-
, (2017/07/31)
Disclosed herein are spirocyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.
COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS
-
Paragraph 00317, (2016/04/20)
The present invention provides compounds of Formula (I) and (II) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.